Patent details
EP2117517 Title: SUSTAINED RELEASE ORAL DOSAGE FORMS OF A PRODRUG OF R-BACLOFEN AND METHODS OF TREATMENT
Basic Information
- Publication number:
- EP2117517
- PCT Application Number:
- PCT/US/2008/050796
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP087275509
- PCT Publication Number:
- WO/2008/086492
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SUSTAINED RELEASE ORAL DOSAGE FORMS OF A PRODRUG OF R-BACLOFEN AND METHODS OF TREATMENT
- French Title of Invention:
- FORMES GALÉNIQUES ORALES À LIBÉRATION PROLONGÉE D'UN PROMÉDICAMENT DE R-BACLOFÈNE ET PROCÉDÉS DE TRAITEMENT
- German Title of Invention:
- VERZÖGERT FREIGESETZTE ORALE DOSIERUNGSFORMEN EINES PRODRUGS VON R-BACLOFEN UND BEHANDLUNGSVERFAHREN DAMIT
- SPC Number:
Dates
- Filing date:
- 10/01/2008
- Grant date:
- 01/06/2011
- EP Publication Date:
- 01/06/2011
- PCT Publication Date:
- 17/07/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/11/2009
- EP B1 Publication Date:
- 01/06/2011
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 10/01/2012
- Expiration date:
- 10/01/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 10/01/2008
- Name:
- XenoPort Inc.
- Address:
- 3410 Central Expressway, Santa Clara, CA 95051, United States (US)
Inventor
1
- Name:
- LEUNG Manshiu
- Address:
- United States (US)
2
- Name:
- CUNDY Kenneth, C.
- Address:
- United States (US)
3
- Name:
- SASTRY Srikonda
- Address:
- United States (US)
4
- Name:
- KIDNEY David, J.
- Address:
- United States (US)
Priority
- Priority Number:
- 884598 P
- Priority Date:
- 11/01/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 9/20;
| Filing date | Document type | Number of pages |
|---|